Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation

Abstract

Post transplantation constrictive bronchiolitis (PTCB) is the most common pulmonary complication among long-term survivors of allogeneic hematopoietic stem cell transplantation (HSCT). It is a late manifestation of GVHD. Its treatment with high-dose systemic corticosteroids and other immunosuppressive regimens is associated with multiple side effects. Topical corticosteroids are used for the treatment of other manifestations of GVHD to minimize these side effects. We conducted a retrospective analysis of a series of adult patients to evaluate the efficacy of high-dose inhaled corticosteroids in the treatment of PTCB. Seventeen patients with new-onset airflow obstruction were diagnosed with PTCB. Their forced expiratory volume in 1 s (FEV1) declined from a median of 84% (range, 56–119) before HSCT to 53% (26–82) after HSCT. All patients received inhaled fluticasone propionate 500–940 μg two times daily. Symptoms of airway obstruction improved and FEV1 stabilized 3–6 months after treatment. We conclude that high-dose inhaled corticosteroids may be effective in the treatment of PTCB and propose a plausible mechanism of its action. A prospective evaluation of its efficacy is warranted.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Milojkovic D, Mufti GJ . Extending the role of allogeneic stem-cell transplantation. Lancet 2001; 357: 652–654.

    Article  CAS  PubMed  Google Scholar 

  2. Kotloff RM, Ahya VN, Crawford SW . Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004; 170: 22–48.

    Article  PubMed  Google Scholar 

  3. Soubani AO, Miller KB, Hassoum PM . Pulmonary complications of bone marrow transplantation. Chest 1996; 109: 1066–1077.

    Article  CAS  PubMed  Google Scholar 

  4. Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Garrett Nichols W et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208–214.

    Article  PubMed  Google Scholar 

  5. Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other later onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.

    Article  CAS  PubMed  Google Scholar 

  6. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED . Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648–656.

    Article  CAS  PubMed  Google Scholar 

  7. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW . Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72: 621–627.

    CAS  PubMed  Google Scholar 

  8. Watkins TR, Chien JW, Crawford SW . Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med 2005; 26: 482–489.

    Article  PubMed  Google Scholar 

  9. Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 2004; 33: 1031–1035.

    Article  CAS  PubMed  Google Scholar 

  10. Bertz H, Afting M, Kreisel W, Duffner U, Greinwald R, Finke J . Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD. Bone Marrow Transplant 1999; 24: 1185–1189.

    Article  CAS  PubMed  Google Scholar 

  11. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991; 144: 1202–1218.

  12. Sanchez J, Torres A, Serrano J, Roman J, Martin C, Perula L et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 403–408.

    Article  CAS  PubMed  Google Scholar 

  13. Bergeron A, Belle A, Chevret S, Ribaud P, Devergie A, Esperou H et al. Combined inhaled steroids and bronchodilators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 547–553.

    Article  CAS  PubMed  Google Scholar 

  14. Chien JW, Martin PJ, Flowers ME, Nichols WG, Clark JC . Implication of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 33: 759–764.

    Article  CAS  PubMed  Google Scholar 

  15. Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A . Long term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004; 33: 509–517.

    Article  CAS  PubMed  Google Scholar 

  16. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP . Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121–129.

    Article  CAS  PubMed  Google Scholar 

  17. Wynn TA . Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol 2004; 8: 583–594.

    Article  Google Scholar 

  18. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J et al. Pulmonary expression of IL13 causes inflammation, mucous hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779–788.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001; 194: 809–821.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Georas SN, Guo J, De Fanis U, Casolaro V . T-helper cell type-2 regulation in allergic disease. Eur Respir J 2005; 26: 1119–1137.

    Article  CAS  PubMed  Google Scholar 

  21. Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Müller NL, King TE . Non-Neoplastic Disorders of the Lower Respiratory Tract. American registry of pathology and the armed forces institute of pathology: Washington, DC, 2002, pp 351–380.

    Google Scholar 

Download references

Acknowledgements

This work was supported by a Multidisciplinary Research Program grant, MD Anderson Cancer Center: Post-Transplantation Constrictive Bronchiolitis, and a grant from the National Institutes of Health (HL072984 to BFD).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Bashoura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bashoura, L., Gupta, S., Jain, A. et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 41, 63–67 (2008). https://doi.org/10.1038/sj.bmt.1705877

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705877

Keywords

This article is cited by

Search

Quick links